Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    Cephalexin Monohydrate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 71Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    31/10/2025 Centrient Pharmaceuticals
    Netherlands
    		 Yuhan Corporation 20140221-151-I-363-04(1) Cephalexin hydrate 2015-07-03 Centrient Pharmaceuticals Spain S.A. Spain Poligono Industrial Urvasa, C/Ripolles, 2 08130 Santa Perpetua de Mogoda (Barcelona), Spain
    31/10/2025 Centrient Pharmaceuticals
    Netherlands
    		 Aging Life Science Co., Ltd. 20140221-151-I-363-04 Cephalexin hydrate 2014-02-21 Centrient Pharmaceuticals Spain S.A. Spain C/Ripolles, n2 Poligono Industrial URVASA Santa Perpetua de Mogoda 08130 BARCELONA SPAIN (POBox 425, 2600 AK Delft, The Netherlands)